Methamphetamine






1981 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 6286 Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 1976 Apr 9
2 424478 Corticosteroid and growth hormone responses to methylamphetamine in depressive illness. Psychol Med 1979 Feb 1
3 828132 [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions]. Nihon Yakurigaku Zasshi 1976 Oct 1
4 1304621 Circadian variation in R-THBP-induced enhancement of the ambulation-increasing effect of methamphetamine on mice. Jpn J Psychiatry Neurol 1992 Dec 3
5 1325059 Pharmacological mechanisms in the cardiovascular effects of methamphetamine in conscious squirrel monkeys. Pharmacol Biochem Behav 1992 Aug 1
6 1361442 Multidimensional behavioral analyses show dynorphin A-(1-13) modulation of methamphetamine-induced behaviors in mice. Eur J Pharmacol 1992 Nov 3 4
7 1374469 Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 1992 May 5
8 1475045 In situ DNA-protein binding: a novel method for detecting DNA-binding activity of transcription factor in brain. Neurosci Lett 1992 Oct 26 1
9 1686311 Involvement of central beta-adrenoceptors in the induction of hypothalamic interleukin-1 beta mRNA by methamphetamine. Neurosci Res 1991 Nov 3
10 1717871 Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system. Neuropharmacology 1991 Jun 3
11 1722253 Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine. J Pharmacol Exp Ther 1991 Dec 2
12 1903446 Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 1991 May 1
13 1905457 Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage. Int J Dev Neurosci 1991 2
14 1922692 Selective effects of behaviorally active doses of methamphetamine on mRNA expression in the gerbil brain. Neuropharmacology 1991 Sep 2
15 1922954 Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus. Neurosci Lett 1991 Jul 8 4
16 1958770 P300 in methamphetamine psychosis. Biol Psychiatry 1991 Oct 1 1
17 1970306 Role of dopamine D-1 and D-2 receptors in the ventral striatum in the turning behaviour of rats. Eur J Pharmacol 1990 Mar 20 1
18 1981946 Neural transplantation in mouse Parkinson's disease. Stereotact Funct Neurosurg 1990 1
19 2093186 Stimulus properties of ring-methyl amphetamine analogs. Pharmacol Biochem Behav 1990 Dec 1
20 2147039 Neurotensin-dopamine interactions in the substantia nigra of the rat brain. J Pharmacol Exp Ther 1990 Nov 2
21 2150044 Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors. Eur J Pharmacol 1990 Oct 23 1
22 2151400 D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl) 1990 2
23 2243598 "On-line" measurement of acetylcholinesterase release from the substantia nigra of the freely-moving guinea-pig. Neuroscience 1990 1
24 2431914 Response of mesolimbic substance P systems to methamphetamine treatment. Eur J Pharmacol 1986 Sep 9 7
25 2436197 Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment. Peptides 1986 Nov-Dec 4
26 2449619 The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain. NIDA Res Monogr 1987 2
27 2498964 Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 1989 1
28 2521903 Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J Pharmacol Exp Ther 1989 Feb 2
29 2539202 Reduction of rat striatal thyrotropin-releasing hormone receptors produced by repeated methamphetamine administration. Biol Psychiatry 1989 Jan 15 1
30 2570704 Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur J Pharmacol 1989 Jun 20 7
31 2580766 A screening method for urinary methamphetamine--latex agglutination inhibition reaction test. Forensic Sci Int 1985 Jan 2
32 2615336 Methamphetamine in antemortem blood and urine by radioimmunoassay and GC/MS. J Anal Toxicol 1989 Sep-Oct 4
33 2753904 Evidence for dual mechanisms involved in methamphetamine-induced increases in striatal preprotachykinin mRNA. J Biol Chem 1989 Aug 5 6
34 2760604 Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration. J Neural Transm 1989 1
35 2770055 Enhancement of ambulation-increasing effect of methamphetamine by peripherally-administered 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) in mice. Jpn J Pharmacol 1989 Jun 3
36 2816096 [Behavioral pharmacological properties of propiverine hydrochloride (P-4) in mice and rats]. Yakubutsu Seishin Kodo 1989 Jun 1
37 2825061 Dopaminergic agents affected neuronal transmission of cholecystokinin in the rat brain. Neuropeptides 1987 Oct 1
38 2875893 The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 1986 Aug 22 2
39 2882825 Tyrosine hydroxylase immunochemistry and quantitative light microscopic studies of the mesolimbic dopamine system in rat brain: effects of chronic methamphetamine administration. Brain Res Bull 1987 Feb 2
40 2884120 Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 1987 Mar 17 2
41 2887434 Effects of amphetamine analogs on neurotensin concentrations in rat brain. Eur J Pharmacol 1987 Jun 12 1
42 2893739 Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur J Pharmacol 1987 Dec 1 1
43 2893856 Effects of methamphetamine on the twitch response in the rat isolated vas deferens. Jpn J Pharmacol 1987 Nov 1
44 2905662 Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur J Pharmacol 1988 Aug 9 1
45 2907386 [Effects of selective D-1 and D-2 dopamine antagonists on methamphetamine-induced behavioral sensitization]. Seishin Shinkeigaku Zasshi 1988 1
46 2943891 Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 1986 Sep 1
47 3083608 Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency. Xenobiotica 1986 Feb 3
48 3135673 Participation of cytochrome P-450 isozymes in N-demethylation, N-hydroxylation and aromatic hydroxylation of methamphetamine. Xenobiotica 1988 May 2
49 3335027 Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res 1988 Feb 1 1
50 3572804 Effect of methamphetamine on neurotensin concentrations in rat brain regions. J Pharmacol Exp Ther 1987 May 4